Ascletis Pharma Inc. (HKG:1672)
Hong Kong · Delayed Price · Currency is HKD 16.87
-0.79 (-4.47%)
Feb 23, 2026, 4:08 PM HKT
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of 17.9 billion as of February 23, 2026. Its market cap has increased by 356.05% in one year.
Market Cap
17.90B
Enterprise Value
15.93B
Revenue
2.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.87
Market Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has increased from 15.69B to 17.90B, an increase of 14.10%. That is a compound annual growth rate of 1.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 18.74B | 66.71% |
| Dec 31, 2025 | 11.24B | 287.10% |
| Dec 31, 2024 | 2.90B | 90.74% |
| Dec 29, 2023 | 1.52B | -70.46% |
| Dec 30, 2022 | 5.15B | 44.13% |
| Dec 31, 2021 | 3.58B | 13.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 31.46B |
| TransThera Sciences (Nanjing) | 27.05B |
| Genscript Biotech | 26.30B |
| PegBio | 26.05B |
| InnoCare Pharma | 25.33B |
| Zai Lab | 17.59B |
| Ascentage Pharma Group International | 17.18B |
| Keymed Biosciences | 16.01B |